- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Automatic Translation feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Antibiotic de–escalation as an antimicrobial stewardship measure in emergency and critical care
-
- Yamashita Chizuru
- Department of Anesthesia and Critical Care Medicine, Fujita Health University School of Medicine
-
- Kawaji Takahiro
- Department of Anesthesia and Critical Care Medicine, Fujita Health University School of Medicine
-
- Nakamura Tomoyuki
- Department of Anesthesia and Critical Care Medicine, Fujita Health University School of Medicine
-
- Ishikawa Kiyohito
- Department of Quality and Safety in Healthcare Division of Infection Control and Prevention, Fujita Health University Hospital
-
- Nishida Osamu
- Department of Anesthesia and Critical Care Medicine, Fujita Health University School of Medicine
Bibliographic Information
- Other Title
-
- 救急,集中治療領域における抗菌薬適正使用の取り組み
Search this article
Description
<p>To save severely septic patients and simultaneously prevent the emergence of resistant bacteria, antibiotics should be administered empirically and then de–escalated promptly, after bacterial susceptibility is confirmed. De–escalation therapy for septic shock is a safe strategy associated with lower mortality; however, its incidence is not high in Intensive Care Units (ICU). From 76 patients admitted to our ICU with a diagnosis of sepsis, most of surgical patients were infected with community–acquired agents including digestive infections. Broad–spectrum antibiotics were used empirically in >90% patients; approximately 20% surgical patients received more than one drug. The adequate rate of empirical therapy was about 95%. Antibiotic de–escalation therapy was performed in 50% of cases receiving broad–spectrum antibiotics. There were various reasons behind the hesitancy to apply de–escalation therapy to severely ill patients: unknown causative agent, no visible improvement of pathological conditions, presence of multiple infection foci, and immunosuppression. In order to promote the proper use of antibiotics in ICU, in addition to a strong cooperation between clinicians, antimicrobial stewardship team, and ICU–dedicated pharmacists, critically ill patients’ treatment should be carried out rationally in accordance with the basic treatment logic for infectious diseases, and in parallel a rapid bacteria diagnostic method should be applied.</p>
Journal
-
- Journal of Japan Society for Surgical Infection
-
Journal of Japan Society for Surgical Infection 17 (4), 182-192, 2020-08-31
Japan Society for Surgical Infection
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390849376470497024
-
- NII Article ID
- 130007932523
-
- ISSN
- 24340103
- 13495755
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed